Related Experiment Video

Updated: Mar 21, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.3K

Epidemiology and Healthcare Burden of Acute-on-Chronic Liver Failure

Alina M Allen1, W Ray Kim2

  • 1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Seminars in Liver Disease
|May 13, 2016
PubMed

Insights

Acute-on-chronic liver failure (ACLF) is a growing global health concern, marked by increased hospitalizations, high mortality, and substantial costs. Early clinical investigation and resource allocation are crucial for effective patient interventions.

Area of Science:

  • Hepatology
  • Internal Medicine
  • Public Health

Background:

  • Chronic liver disease, including cirrhosis from viral hepatitis, alcohol, and NAFLD, causes significant global morbidity and mortality.
  • Acute clinical deterioration of chronic liver disease represents a critical healthcare burden with high mortality risk.
  • Acute-on-chronic liver failure (ACLF) is increasingly recognized, though a universal definition is lacking.

Purpose of the Study:

  • To highlight the growing burden of acute-on-chronic liver failure (ACLF).
  • To underscore the urgency for clinical investigation and resource allocation for ACLF patients.

Main Methods:

  • The abstract does not specify methods but discusses epidemiological trends and healthcare costs.
  • Analysis of hospitalization data and associated costs for ACLF.

Main Results:

  • Hospitalizations for ACLF have increased significantly in the U.S. over the past decade.
  • ACLF is associated with a high fatality rate and incurs extremely high healthcare costs.
  • These costs exceed those of other common inpatient conditions.

Conclusions:

  • ACLF represents a substantial and increasing disease burden globally.
  • There is an urgent need for further epidemiological research to understand ACLF trends.
  • Timely and effective interventions require dedicated healthcare resources and clinical investigation.

More Related Videos

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury07:27

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury

Published on: October 21, 2017

12.5K

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
249
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.2K
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
27
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
331
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
467
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
858